Could AI be the Antidote to ‘Sick Care’ in America?
Meeting people where they are with personalized AI-powered patient outreach could help traditional healthcare move beyond reactive medicine.
Meeting people where they are with personalized AI-powered patient outreach could help traditional healthcare move beyond reactive medicine.
With regulatory scrutiny intensifying and the demand for speed, compliance, and clarity growing, understanding the nuanced differences between AI approaches is essential for payers, providers, and patients alike.
We are only beginning to see how AI can impact women's health. As these technologies advance and become more integrated into healthcare workflows, we can expect more personalized care pathways that address women's needs across different life stages.
When paired with the expertise of health care providers, who serve as guides, partners in care, and healers, we have the critical elements in the formula for providing the patient with quality, personalized care, not merely on an episodic basis, but as the foundation of improved whole person care to take them through their life’s journeys.
The opportunity ahead is significant. Humanized AI can close the gaps that lead to disengagement, improve outcomes through proactive communication, and give providers the bandwidth to focus where they’re needed most.
Caregivers are a backbone of serious illness care, but they cannot carry the system alone. We have reached a point where failing to support them is indistinguishable from failing patients.
We have to cover medical nutrition therapy for those who need it most, including Medicare beneficiaries. Almost all commercial payers are already doing this - the government needs to catch up.
From the heavy emphasis on limiting all ultra-processed foods and eliminating added sugars to placing saturated fats at the top of the pyramid, the new DGAs provide a framework, but highlight areas that still need nuance, clarity, and practical context.
It reduced cravings, dulled alcohol’s “buzz,” and carried no risk of addiction. By every measure, naltrexone should have immediately become a major triumph. Instead, it flopped because the institutions charged with treating addiction refused to use it. Now considered a gold standard, it survived because patients and communities kept it alive.
Programs that combine personal outreach with smart use of technology close more care gaps, improve quality measures, build member loyalty and improve retention.
As specialty therapies expand and chronic conditions rise, infusion services must be viewed as both clinically intensive and deeply human.
Here are some practical strategies to build programs that address these challenges and ultimately achieve real, lasting improvement and patient success.
Patients live in the real world, where jobs are lost, stress piles up, caregiving duties overwhelm, and side effects make a condition feel worse than the cure. These complexities require more than outreach. They require understanding.
The same forces now at play in medical aesthetics will soon appear in every therapeutic category where treatment overlaps with identity, from hormones to nootropics to genetic optimization.